Aclaris Therapeutics financial statements

애클래리스 테라퓨틱스NASDAQ:ACRS · Nasdaq · Healthcare · sector #16
$3.70-13.35%
2026-10-06 close · prelim

Aclaris Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $19M. 2024 operating profit was −$142M.

Reported results

Aclaris Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q